PMFA
PETX

Plante Moran Financial Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Plante Moran Financial Advisors’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-166
Closed -$1K – 1017
2016
Q2 		$1K Hold
166
– – ﹤0.01% 886
2016
Q1 		$1K Buy
+166
New +$624 ﹤0.01% 829

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Plante Moran Financial Advisors's PETX Position: Q3 2016 in Review

Plante Moran Financial Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2016, closing a stake of 166 shares — an estimated $1K sold.

Plante Moran Financial Advisors first reported a position in PETX in Q1 2016 and held it in 2 quarters. The position peaked at $1K in Q2 2016. 129 funds tracked by Wall St. Rank hold PETX as of Q3 2016.

  • Plante Moran Financial Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 166 Aratana Therapeutics, Inc. shares in Q3 2016, an estimated $1K.
  • Plante Moran Financial Advisors first reported a position in Aratana Therapeutics, Inc. in Q1 2016 and held it in 2 quarters.
  • Plante Moran Financial Advisors's Aratana Therapeutics, Inc. position peaked at $1K in Q2 2016.
  • 129 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2016, filed 3 Nov 2016.